iSpecimen Inc. Files Definitive Proxy Statement

TL;DR

iSpecimen DEF 14A filed: Proxy materials for shareholder vote are out. Expect votes on directors & exec pay.

AI Summary

iSpecimen Inc. filed its definitive proxy statement on October 14, 2025, for its annual meeting of stockholders. The filing, designated as DEF 14A, outlines the company's governance and proposals to be voted on by shareholders. Key details regarding executive compensation, director elections, and other corporate matters are expected to be presented.

Why It Matters

This filing is crucial for shareholders as it details the proposals they will vote on, including director elections and executive compensation, directly impacting the company's future direction and governance.

Risk Assessment

Risk Level: medium — DEF 14A filings are routine but can reveal important information about executive compensation, board composition, and shareholder proposals that may indicate underlying company performance or strategic shifts.

Key Players & Entities

• iSpecimen Inc. (company) — Registrant
• 0001213900-25-098780 (filing_id) — Accession Number
• 20251014 (date) — Filing Date
• 20251030 (date) — Period of Report
• 8 Cabot Road, Suite 1800, Woburn, MA 01801 (address) — Business and Mail Address

FAQ

From the Filing

0001213900-25-098780.txt : 20251014 0001213900-25-098780.hdr.sgml : 20251014 20251014163042 ACCESSION NUMBER: 0001213900-25-098780 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20251030 FILED AS OF DATE: 20251014 DATE AS OF CHANGE: 20251014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 251392171 BUSINESS ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 DEF 14A 1 ea0256032-03.htm PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________ SCHEDULE 14A INFORMATION __________________________________ Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant   ☒ Filed by a Party other than the Registrant   ☐ Check the appropriate box: ☐   Preliminary Proxy Statement ☐   Confidential, for Use of the Commission Only (as permitted by Rule 14a -6 (e)(2)) ☒   Definitive Proxy Statement ☐   Definitive Additional Materials ☐   Soliciting Material Pursuant to § 240.14a -12 iSpecimen Inc. (Name of Registrant as Specified in its Charter) N/A (Name of Person(s) Filing Proxy Statement, if other than the Registrant) PAYMENT OF FILING FEE (Check the appropriate box): ☒   No fee required. ☐   Fee paid previously with preliminary materials. ☐   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a -6 (i)(1) and 0 -11 .   Table of Contents iSpecimen Inc. 8 Cabot Road, Suite 1800 Woburn, MA 08101 October 14, 2025 Dear Fellow Stockholders: On behalf of the board of directors (“Board of Directors”) of iSpecimen Inc., I cordially invite you to attend the 2025 special meeting of stockholders (the “Special Meeting”) of iSpecimen Inc., which will be held virtually via the internet, commencing at 10:00 a.m. Eastern Time on October 30, 2025. In order to attend the meeting, you must log on to www.virtualshareholdermeeting.com / ISPC2025SM and enter the 16 -digit control number included in our Notice of Internet Availability of Proxy Materials, on your proxy card or in the instructions that accompanied your proxy materials. The Special Meeting will be held for the following purposes: 1.        To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation to effect a reverse stock split of our outstanding shares of common stock, par value $0.0001 per share, at a ratio, ranging from one -for -ten (1:10) to one -for -one hundred (1:100), with the exact ratio to be set within that range at the discretion of our Board of Directors without further approval or authorization of our stockholders; 2.        To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of capital stock from 250,000,000 to 1,000,000,000 shares; 3.        To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the potential issuance of shares of common stock (or securities convertible into or exercisable for common stock), in one or more non -public financ